77.4
[]. Harpreet Singh Pawar, et al. Comparative evaluation of therapeutic efficacy of intra-articular oxaceprol with conventional modalities in osteoarthritis animal model. Clin Rheumatol. 0 Aug;7():95-0.
[]. Ionac M et al. Oxaceprol, an atypical inhibitor of inflammation and joint damage. Pharmacol Res, 996 Jun, (6):67-7.
[]. M Ionac, et al. Oxaceprol, an atypical inhibitor of inflammation and joint damage. Pharmacol Res. 996 Jun;(6):67-7.
[4]. M J Parnham, et al. Antirheumatic agents and leukocyte recruitment. New light on the mechanism of action of oxaceprol. Biochem Pharmacol. 999 Jul 5;5():09-5.
[5]. A Veihelmann, et al. Oxaceprol, an atypical inhibitor of inflammation, reduces leukocyte adherence in mouse antigen-induced arthritis. Acta Orthop Scand. 00 Jun;7():9-.
H
P6-P64-P70-P7-P0-P0+P5-P04+P40-P05+P5+P-P0-P6+P64-P40+P-P405-P50
59
![]()
![]()
![]()